Only ⅔ of FDA-approved biosimilars have launched.Measles outbreak continues.UnitedHealth profits fall.Super-Earths.‘Bone Collector’ caterpillars.NFL Draft comes to Green Bay.
April 28, 2025
- Merck KGaA’s Rare Tumor Strategy Takes Shape With $3.9B SpringWorks Acquisition
- Medicare Advantage Insurers Often Use Rewards and Incentives to Encourage Enrollees to Complete Health Risk Assessments (HRAs)
- Value-Based Care Gets Real
- It’s Time for Medical Malpractice Insurance to Emerge from the Stone Age
Headlines
